The association of inflammatory cytokines such as IL-6 and cognitive impairment in both prostate cancer patients undergoing ADT and AD patients merits further scrutiny with a focus on both cognitive measures and physiological effects. This evidence concerns the gene IL6 and Alzheimer disease.